119 related articles for article (PubMed ID: 850579)
1. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
Barlow JJ; Piver MS
Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
Lele SB; Piver MS; Barlow JJ
Obstet Gynecol; 1978 Jan; 51(1):101-4. PubMed ID: 619324
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in advanced ovarian cancer.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
[TBL] [Abstract][Full Text] [Related]
4. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
Hreshchyshyn MM
Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
[TBL] [Abstract][Full Text] [Related]
5. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
8. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
[TBL] [Abstract][Full Text] [Related]
9. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
[TBL] [Abstract][Full Text] [Related]
10. Endodermal sinus tumor: a report of two sustained remissions treated postoperatively with a combination of actinomycin D, 5-fluorouracil, and cyclophosphamide.
Forney JP; Di Saia PJ; Morrow CP
Obstet Gynecol; 1975 Feb; 45(2):186-9. PubMed ID: 1118091
[TBL] [Abstract][Full Text] [Related]
11. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
Israël L; Lepage E; Breau JL; Aguilera J
Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
[TBL] [Abstract][Full Text] [Related]
12. Quadrichemotherapy for advanced ovarian carcinoma.
Kessinger A; Foley JF; Lemon HM
Obstet Gynecol; 1976 Aug; 48(2):134-6. PubMed ID: 940644
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of ovarian cancer. New approaches to treatment.
Smith JP; Rutledge F; Wharton JT
Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
[No Abstract] [Full Text] [Related]
14. Chemotherapy of ovarian cancer.
Dimitriades M; Papadimitriou GC; Razis DV; Panopoulos C; Midoulas N
Int Surg; 1978 Feb; 63(2):81-3. PubMed ID: 632023
[TBL] [Abstract][Full Text] [Related]
15. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Smith JP; Rutledge FN
Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778
[TBL] [Abstract][Full Text] [Related]
16. Histologic grade in advanced ovarian cancer.
Ozols RF; Garvin AJ; Costa J; Simon RM; Young RC
Cancer Treat Rep; 1979 Feb; 63(2):255-63. PubMed ID: 109199
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of ovarian cancer: past and present.
Young RC
Semin Oncol; 1975 Sep; 2(3):267-76. PubMed ID: 827024
[No Abstract] [Full Text] [Related]
18. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
[TBL] [Abstract][Full Text] [Related]
19. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
Park RC; Blom J; Disaia PJ; Lagasse LD; Blessing JA
Cancer; 1980 May; 45(10):2529-42. PubMed ID: 7378989
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
